Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal
Disease Category: Chronic Pain
Trial Information
HORIZON Therapeutics protocol HZ-CA-301: A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment
Horizon Therapeutics is conducting a clinical research study
evaluating an investigational medication that combines a medication
with proven pain relief (NSAID) with proven stomach protection-into
one singe pill. Published studies show that NSAID pain relievers
taken alone can cause stomach ulcers in up to 1 in 4 people who
take them for chronic pain relief.
Compensation for time and travel will be provided.
The study requires that you must be:
- 40 years or older
- suffering from chronic pain such as: osteoarthritis, rheumatoid
arthritis, lower back or other joint-related pain
- interested in participating in a clinical study that closely
monitors your health
Compensation for time and travel will be provided.
Study participation includes, at no cost to
you:
- study visits with experienced medical professionals
- study drug for up to 7 months
- study procedures and evaluations
Gastroenterology Research Associates, LLC
65 Ridgedale Avenue
Cedar Knolls, NJ 07927
Phone: 973-401-0500 ext 111 or 101
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
